Why Is Double Marker Test Done During Pregnancy?

The double marker test during pregnancy is an important first-trimester screening test that helps estimate the risk of certain chromosomal conditions.

Pregnancy comes with a surprising number of blood tests.

Some check your blood group.

Some look for infections.

Others assess hormone levels.

Then there is one test that many parents hear about for the first time during their first-trimester appointments:

The Double Marker Test.

The name sounds technical.

Almost mysterious.

And for many expectant parents, it raises an immediate question:

“What exactly is it testing?”

The answer is simpler than most people expect.

The Double Marker Test is an early pregnancy blood test that helps estimate the likelihood of certain chromosomal abnormalities in the baby.

It does this by measuring two substances naturally present in the mother’s blood: Pregnancy-Associated Plasma Protein-A (PAPP-A) and free beta-human Chorionic Gonadotropin (free β-hCG).

These markers are used to calculate risk rather than provide a diagnosis.

(Shiefa et al. 2013) describe these two markers as the foundation of first-trimester maternal serum screening.

The Blood Test Working Behind The Scenes

One reason many parents are unfamiliar with the Double Marker Test during pregnancy is that it often receives less attention than the NT scan.

People tend to remember ultrasounds.

They remember seeing tiny hands and feet.

They remember hearing the sonographer explain measurements.

Blood tests, however, often happen quietly in the background.

Yet the Double Marker Test plays an important role in first-trimester screening.

Its results are frequently combined with:

• Maternal age
• Gestational age
• NT (Nuchal Translucency) scan findings

Together, these pieces of information help healthcare providers estimate the likelihood of chromosomal conditions such as :

Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).

Why Is It Called A “Double” Marker Test During Pregnancy?

The name comes from the fact that the test measures two biochemical markers.

1. PAPP-A

Pregnancy-Associated Plasma Protein-A is a protein produced by the placenta.

Research has shown that unusually low PAPP-A levels during the first trimester may be associated with an increased risk of certain chromosomal abnormalities, particularly Down syndrome and Trisomy 18.

2. Free β-hCG

Human chorionic gonadotropin (hCG) is the hormone that pregnancy tests detect.

The Double Marker Test specifically measures the free beta component of this hormone.

Higher-than-expected free β-hCG levels may be associated with an increased likelihood of Down syndrome, while different patterns may be seen in other chromosomal conditions.

Individually, these markers provide limited information.

Together, they become much more useful.

When Is The Double Marker Test Performed?

Timing matters.

A lot.

The test is usually performed during the first trimester, typically between 11 and 14 weeks of pregnancy, when the biochemical markers provide the most useful screening information.

This timing is not random.

Researchers discovered that the combination of maternal serum markers and first-trimester ultrasound findings is particularly effective during this narrow window of pregnancy.

If performed too early or too late, the predictive value decreases.

That is why healthcare providers carefully schedule the test.

The Test Does Not Diagnose Anything

This is probably the most important concept in the entire article.

The Double Marker Test is a screening test.

Not a diagnostic test.

Those two terms are often confused.

Screening Test

Estimates risk.

Diagnostic Test

Confirms whether a condition is present.

The Double Marker Test belongs firmly in the screening category.

A “high-risk” result does not mean the baby definitely has a chromosomal abnormality.

A “low-risk” result does not guarantee everything is normal.

Instead, the test helps identify pregnancies that may benefit from additional evaluation.

Think of it as a risk assessment tool rather than a yes-or-no answer.

Why Doctors Often Recommend The NT Scan Alongside It

One of the most effective approaches to first-trimester screening combines:

• NT Scan
• PAPP-A
• Free β-hCG
• Maternal age

This combination is often referred to as combined first-trimester screening.

According to (Nicolaides et al. 2005) landmark review,

combining fetal nuchal translucency measurements with maternal serum free β-hCG and PAPP-A can identify approximately 90% of fetuses with Trisomy 21 while maintaining a false-positive rate of around 5%.

That is why many healthcare providers discuss the NT scan and Double Marker Test together.

They work best as partners.

What Research Has Discovered

Over the last two decades, researchers have studied first-trimester screening extensively.

The findings have been remarkably consistent.

Combined screening approaches that use NT measurements and Double Marker blood testing achieve significantly better detection rates than relying on maternal age alone.

Studies have reported detection rates ranging from approximately 82% to 95% for common chromosomal abnormalities while maintaining relatively low false-positive rates.

These discoveries transformed prenatal screening.

Instead of waiting until later in pregnancy, healthcare providers can now estimate risk much earlier.

For many families, earlier information means more options, more preparation, and more reassurance.

Does Every Pregnant Woman Need A Double Marker Test?

The answer depends on several factors:

• Local screening practices
• Availability of NIPT
• Individual risk factors
• Personal preferences
• Healthcare provider recommendations

In some settings, NIPT has become increasingly common.

In others, combined first-trimester screening remains the standard approach.

Both strategies aim to provide meaningful information about chromosomal risk during early pregnancy.

The right choice often depends on the individual situation.

A Small Reassurance Before Your Blood Test

Many women become anxious when they hear the words:

“chromosomal screening.”

That reaction is completely understandable.

But it helps to remember why the test exists.

The Double Marker Test is not looking for certainty.

It is looking for patterns.

Patterns that may suggest a higher or lower likelihood of specific chromosomal conditions.

For most women, the test provides reassurance.

For others, it identifies situations where additional testing may be helpful.

Either way, information gained during the first trimester can help guide the rest of the pregnancy journey with greater confidence.

What Does A High-Risk Double Marker Result Mean?

This is often the moment that causes the most anxiety.

Many parents receive a report containing terms such as:

• Low Risk
• Intermediate Risk
• High Risk

And naturally, their minds jump to the worst-case scenario.

But before panic takes over, it is important to understand what these terms actually mean.

A high-risk result does not mean your baby has a chromosomal abnormality.

Instead, it means the screening test has identified a higher-than-average probability that one may be present.

Think of it like a weather forecast.

A forecast predicting a 70% chance of rain does not guarantee rain.

It simply suggests that rain is more likely.

The Double Marker Test works in a similar way.

It estimates probability.

It does not provide certainty.

What Happens After A High-Risk Result?

If a screening result indicates increased risk, your healthcare provider may discuss additional testing options.

These may include:

Non-Invasive Prenatal Testing (NIPT)

NIPT is a blood test that analyzes cell-free DNA circulating in the mother’s bloodstream.

Chorionic Villus Sampling (CVS)

A diagnostic procedure performed during the first trimester.

Amniocentesis

A diagnostic test that analyzes amniotic fluid surrounding the baby.

Detailed Ultrasound Assessment

Additional imaging may be recommended to gather further information.

The specific pathway depends on individual circumstances, gestational age, ultrasound findings, and personal preferences.

Most importantly:

A screening result is usually the beginning of a conversation, not the final answer.

How Accurate Is Double Marker Testing?

One reason the Double Marker Test became widely adopted is its ability to identify many pregnancies at increased risk for chromosomal abnormalities during the first trimester.

When combined with NT measurements and maternal age, first-trimester screening has demonstrated impressive performance.

A multicenter study by Nicolaides and colleagues reported detection rates approaching 90% for Down syndrome pregnancies with a false-positive rate of approximately 5%. (Nicolaides et al., 2005)

Additional studies have reported detection rates ranging between 82% and 95%, depending on the screening model used and the population studied. (Park et al., 2016)

These numbers are significantly better than relying on maternal age alone.

However, they also remind us that no screening test is perfect.

Why The Test Can Sometimes Be Wrong

Every screening test has limitations.

The Double Marker Test is no exception.

Sometimes a pregnancy may receive a high-risk result even though the baby is healthy.

This is known as a false positive.

Conversely, a pregnancy may receive a low-risk result even though a chromosomal abnormality is present.

This is known as a false negative.

Researchers have consistently emphasized that first-trimester screening is highly effective but should never be viewed as diagnostic. (Li et al., 2015)

This is why abnormal screening results are typically followed by additional testing rather than immediate conclusions.

Double Marker Test Vs NIPT During Pregnancy

This is one of the most common questions parents ask today.

Especially as NIPT becomes increasingly available.

Double Marker Test

• Measures PAPP-A and free β-hCG
• Usually combined with NT scan
• Estimates chromosomal risk
• More affordable in many healthcare settings

NIPT

• Analyzes cell-free DNA
• Higher detection rates
• Lower false-positive rates
• More expensive in many regions

Research consistently shows that NIPT provides superior screening performance for common trisomies.

However, combined first-trimester screening remains a valuable and widely used option, particularly when NIPT is unavailable or not preferred. (Nicolaides et al. 2011)

The important thing to remember is that these tests are not necessarily competitors.

They are different tools designed to answer similar questions.

Why Some Women Still Choose Double Marker Testing

With NIPT becoming more common, some parents wonder why the Double Marker Test still exists.

The answer is simple.

Accessibility.

Cost.

Availability.

And clinical value.

Combined first-trimester screening remains an established and evidence-based approach used in healthcare systems worldwide.

For many families, it provides useful information without requiring more advanced testing.

And when combined with an NT scan, it continues to perform remarkably well. (Santorum et al., 2017)

What Research Has Discovered

Over the past two decades, first-trimester screening has undergone extensive evaluation.

Researchers have repeatedly demonstrated that combining:

• Maternal age
• NT measurements
• PAPP-A
• Free β-hCG

provides significantly better detection rates than any single factor alone.

A large validation study reported detection rates of:

• 90% for Trisomy 21
• 97% for Trisomy 18
• 92% for Trisomy 13

when modern first-trimester screening protocols were used. (Santorum et al., 2017)

These findings helped establish combined first-trimester screening as one of the cornerstones of prenatal care.

Things Nobody Tells You About Double Marker Testing

Most Women Spend More Time Worrying Than Necessary

The blood draw usually takes only a few minutes.

The waiting period often feels much longer.

High Risk Does Not Mean Diagnosis

Many parents misunderstand this point.

A screening result is an estimate.

Not a confirmation.

Low Risk Does Not Mean Zero Risk

A reassuring result lowers the likelihood.

It does not eliminate it entirely.

The Test Works Best As Part Of A Bigger Picture

Healthcare providers interpret results alongside scans, clinical history, and other findings.

No single blood test determines the outcome of a pregnancy.

What My Patients Often Ask

“Did I Do Something Wrong If My Result Is High Risk?”

No.

Chromosomal abnormalities are not caused by something you ate, a stressful day at work, or forgetting a prenatal vitamin.

“Can The Double Marker Test Harm My Baby?”

No.

The test only requires a maternal blood sample.

“Should I Choose NIPT Instead?”

This depends on your circumstances, budget, healthcare provider’s recommendations, and personal preferences.

“Can The Test Tell Whether My Baby Is Healthy?”

Not completely.

It screens for specific chromosomal abnormalities.

It does not assess every aspect of fetal health.

A Note From A Physiotherapist

One thing I have learned from working with expectant mothers is that uncertainty is often harder than bad news.

Many women find themselves worrying about possibilities that never become reality.

The Double Marker Test is designed to reduce uncertainty, not create it.

Most results are reassuring.

And when additional testing is recommended, it creates opportunities for more information rather than reasons for immediate alarm.

Sometimes the purpose of screening is not to provide answers.

Sometimes it is to guide the next question.

What The Double Marker Test Cannot Tell You

The Double Marker Test is valuable.

But it has limits.

It cannot predict personality.

It cannot predict intelligence.

It cannot guarantee a healthy pregnancy.

It cannot identify every genetic condition.

It cannot replace detailed ultrasound assessments.

Like every screening tool, it answers specific questions rather than every question.

One Less Thing To Worry About

Many women hear the words “chromosomal screening” and immediately become anxious.

That reaction is understandable.

But it helps to remember why screening exists.

The purpose is not to look for problems.

The purpose is to provide information.

And for most families, that information is reassuring.

If Nobody Has Told You This Today…

Pregnancy can sometimes feel like a series of tests, scans, appointments, and waiting periods.

It is easy to forget that every test is designed with one goal in mind:

Supporting the healthiest possible pregnancy journey.

The Double Marker Test is simply one of those tools.

A tool that helps healthcare providers understand risk a little better and guide care a little more effectively.

Final Thoughts

The Double Marker Test remains one of the most important first-trimester screening tools used in prenatal care.

By measuring PAPP-A and free β-hCG and combining those findings with maternal age and NT scan results,

healthcare providers can estimate the likelihood of common chromosomal abnormalities early in pregnancy.

Research has shown that combined first-trimester screening can detect approximately 82-95% of affected pregnancies while maintaining relatively low false-positive rates. (Park et al., 2016)

Most importantly, the Double Marker Test is a screening test, not a diagnosis.

Its purpose is to identify pregnancies that may benefit from additional evaluation,

provide reassurance when risk appears low, and support informed decision-making throughout pregnancy.

Sometimes two small blood markers can provide information that helps shape an entire pregnancy journey.

Stay tuned with us for more health related topics.

Follow us on LinkedIn and Instagram for more.

Medical Disclaimer!

This article has been reviewed and written under the guidance of our Head Physiotherapist, Dr. Kruti Raj (PT, MUHS,CPT,CMPT). The information shared is intended for educational purposes only and should not be considered a substitute for personalized medical advice, diagnosis, or treatment.

Please consult us or any other qualified healthcare professional before beginning any exercise program, especially if you are experiencing pain, recovering from injury, or managing a medical condition.